{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:42:16Z","timestamp":1736314936676,"version":"3.32.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11920-024-01558-5","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T08:01:48Z","timestamp":1733212908000},"page":"816-821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["How to Mitigate Risk in the Treatment of Patients with Borderline Personality Disorder"],"prefix":"10.1007","volume":"26","author":[{"given":"Richard G","family":"Hersh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"8","key":"1558_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/jama.2023.0589","volume":"329","author":"F Leichsenring","year":"2003","unstructured":"Leichsenring F, Heim N, Leweke F, Spitzer C, Steinert C, Kernberg OF. Borderline personality disorder: a review. JAMA 28. 2003;329(8):670\u20139. https:\/\/doi.org\/10.1001\/jama.2023.0589.","journal-title":"JAMA 28"},{"issue":"2","key":"1558_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1176\/appi.ajp.158.2.295","volume":"158","author":"DS Bender","year":"2001","unstructured":"Bender DS, Dolan RT, Skodol AE, Sanislow CA, Dyck IR, McGlashan TH, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry. 2001;158(2):295.","journal-title":"Am J Psychiatry"},{"issue":"5\u20136","key":"1558_CR3","first-page":"39","volume":"10","author":"RA Sansone","year":"2013","unstructured":"Sansone RA, Sansone LA. Responses of mental health clinicians to patients with borderline personality disorder. Innov Clin Neurosci. 2013;10(5\u20136):39\u201343.","journal-title":"Innov Clin Neurosci"},{"issue":"3","key":"1558_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/j.1440-1665.2006.0229","volume":"14","author":"R Krawitz","year":"2006","unstructured":"Krawitz R, Batcheler M. Borderline personality disorder: a pilot survey about clinician views on defensive practice. Australas Psychiatry. 2006;14(3):320\u20132. https:\/\/doi.org\/10.1080\/j.1440-1665.2006.0229.","journal-title":"Australas Psychiatry"},{"issue":"5","key":"1558_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1176\/ajp.146.5.597","volume":"146","author":"TG Gutheil","year":"1989","unstructured":"Gutheil TG. Borderline personality disorder, boundary violations, and patient- therapist sex: medicolegal pitfalls. Am J Psychiatry. 1989;146(5):597.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1558_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1176\/ajp.142.1.9","volume":"142","author":"TG Gutheil","year":"1985","unstructured":"Gutheil TG. Medicolegal pitfalls in the treatment of borderline patients. Am J Psychiatry. 1985;142(1):9\u201314.","journal-title":"Am J Psychiatry"},{"key":"1558_CR7","doi-asserted-by":"publisher","unstructured":"Madan A, Oldham JM, Gonzalez S, Fowler JC. Reducing adverse polypharmacy in patients with borderline personality disorder: An empirical case study.\u00a0 Prim Care Companion CNS Disord 30. 2015;17(4):\u00a0https:\/\/doi.org\/10.4088\/PCC.14m01760.","DOI":"10.4088\/PCC.14m01760"},{"issue":"7","key":"1558_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/s41386-023-01540-4","volume":"48","author":"SK Fineberg","year":"2023","unstructured":"Fineberg SK, Choi EY, Shapiro-Thompson R, Dhaliwal K, Neustadter E, Sakheim M, et al. A pilot randomized controlled trial of ketamine in Borderline personality disorder. Neuropsychopharmacology. 2023;48(7):991\u20139. https:\/\/doi.org\/10.1038\/s41386-023-01540-4.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"1558_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/02698811241232548","volume":"38","author":"A Marrocu","year":"2024","unstructured":"Marrocu A, Kettner H, Weiss B, Zeifman RJ, Erritzoe D, Carhart-Harris RL. Psychiatric risks for worsened mental health after psychedelic use. J Psychopharmacol. 2024;38(3):225\u201335. https:\/\/doi.org\/10.1177\/02698811241232548.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"1558_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1176\/appi.ap.12110194","volume":"37","author":"RA Sansone","year":"2013","unstructured":"Sansone RA, Kay J, Anderson JL. Resident didactic education in borderline personality disorder: is it sufficient? Acad Psychiatry 1. 2013;37(4):287\u20138. https:\/\/doi.org\/10.1176\/appi.ap.12110194.","journal-title":"Acad Psychiatry 1"},{"issue":"4","key":"1558_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/01410768231164780","volume":"116","author":"R Mulder","year":"2023","unstructured":"Mulder R, Tyrer P. Borderline personality disorder: A spurious condition unsupported by science that should be abandoned. J R Soc Med. 2023;116(4):148\u201350. https:\/\/doi.org\/10.1177\/01410768231164780.","journal-title":"J R Soc Med."},{"issue":"2","key":"1558_CR12","first-page":"41","volume":"46","author":"HS Akiskal","year":"1985","unstructured":"Akiskal HS, Chen SE, Davis GC, Puzantian VR, Kashgarian M, Bolinger JM. Borderline: an adjective in search of a noun. J Clin Psychiatry. 1985;46(2):41\u20138.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"1558_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/0959-353505057620","volume":"15","author":"C Shaw","year":"2005","unstructured":"Shaw C, Proctor G. Women at the margins: a critique of the diagnosis of borderline personality disorder. Feminism Psychol. 2005;15(4):483.https:\/\/doi.org\/10.1177\/0959-353505057620","journal-title":"Feminism Psychol"},{"issue":"5","key":"1558_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1176\/appi.ajp.2009.08121825","volume":"166","author":"JG Gunderson","year":"2009","unstructured":"Gunderson JG. Borderline personality disorder: ontogeny of a diagnosis. Am J Psychiatry. 2009;166(5):530\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.2009.08121825.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1558_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/jts.2490050305","volume":"5","author":"JL Herman","year":"1992","unstructured":"Herman JL. Complex PTSD: a syndrome in survivors of prolonged and repeated trauma. J Trauma Stress. 1992;5(3):377\u201391. https:\/\/doi.org\/10.1002\/jts.2490050305.","journal-title":"J Trauma Stress"},{"issue":"3","key":"1558_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00131746-200405000-00005","volume":"10","author":"ER Lequesne","year":"2004","unstructured":"Lequesne ER, Hersh RG. Disclosure of a diagnosis of borderline personality disorder. J Psychiatr Pract. 2004;10(3):170.","journal-title":"J Psychiatr Pract"},{"issue":"10","key":"1558_CR17","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1176\/ajp.156.10.1570","volume":"156","author":"M Zimmerman","year":"1999","unstructured":"Zimmerman M, Mattia JI. Differences between clinical and research practices in diagnosing borderline personality disorder. Am J Psychiatry. 1999;156(10):1570\u20134. https:\/\/doi.org\/10.1176\/ajp.156.10.1570.","journal-title":"Am J Psychiatry"},{"issue":"8","key":"1558_CR18","first-page":"18","volume":"5","author":"RA Sansone","year":"2009","unstructured":"Sansone RA, Sansone LA. Borderline personality disorder: are proliferative symptoms characteristic? Psychiatry (Edgmont). 2009;5(8):18\u201321.","journal-title":"Psychiatry (Edgmont)"},{"issue":"2","key":"1558_CR19","first-page":"91","volume":"26","author":"J Reich","year":"2014","unstructured":"Reich J, Schatzberg A. An empirical data comparison of regulatory agency and malpractice legal problems for psychiatrists. Ann Clin Psychiatry. 2014;26(2):91\u20136.","journal-title":"Ann Clin Psychiatry"},{"issue":"4","key":"1558_CR20","first-page":"297","volume":"23","author":"JH Reich","year":"2011","unstructured":"Reich JH, Maldonado J. Empirical findings on legal difficulties among practicing psychiatrists. Annals Clin Psychiatry: Official J Am Acad Clin Psychiatrists. 2011;23(4):297\u2013307.","journal-title":"Annals Clin Psychiatry: Official J Am Acad Clin Psychiatrists"},{"issue":"3","key":"1558_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1521\/pedi.18.3.240.35443","volume":"18","author":"J Paris","year":"2004","unstructured":"Paris J. Is hospitalization useful for suicidal patients with borderline personality disorder? J Pers Disord. 2004;18(3):240\u20137. https:\/\/doi.org\/10.1521\/pedi.18.3.240.35443.","journal-title":"J Pers Disord"},{"key":"1558_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.genhosppsych.2020.08.014","volume":"67","author":"O Mammen","year":"2020","unstructured":"Mammen O, Tew J, Painter T, Bettinelli E, Beckjord J. Communicating suicide risk to families of chronically suicidal borderline personality disorder patients to mitigate malpractice risk. Gen Hosp Psychiatry. 2020;67:51\u20137. https:\/\/doi.org\/10.1016\/j.genhosppsych.2020.08.014.","journal-title":"Gen Hosp Psychiatry"},{"issue":"11","key":"1558_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/medethics-2021-10721610.1136\/medethics-2021-107216","volume":"48","author":"E Sims","year":"2022","unstructured":"** Sims E, Nelson KJ, Sisti D. Borderline personality disorder, therapeutic privilege, integrated care: is it ethical to withhold a psychiatric diagnosis? J Med Ethics. 2022;48(11):801\u20134. https:\/\/doi.org\/10.1136\/medethics-2021-107216.","journal-title":"J Med Ethics"},{"issue":"1","key":"1558_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11920-010-0167-x","volume":"13","author":"I Weinberg","year":"2011","unstructured":"Weinberg I, Ronningstam E, Goldblatt MJ, Schechter M, Maltsberger JT. Common factors in empirically supported treatments of borderline personality disorder. Curr Psychiatry Rep. 2011;13(1):60\u20138. https:\/\/doi.org\/10.1007\/s11920-010-0167-x.","journal-title":"Curr Psychiatry Rep"},{"issue":"9","key":"1558_CR25","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1176\/appi.ps.201900073","volume":"70","author":"EA Iliakis","year":"2019","unstructured":"Iliakis EA, Sonley AKI, Ilagan GS, Choi-Kain LW. Treatment of borderline personality disorder: is supply adequate to meet public health needs? Psychiatr Serv. 2019;70(9):772\u201381. https:\/\/doi.org\/10.1176\/appi.ps.201900073.","journal-title":"Psychiatr Serv"},{"issue":"4","key":"1558_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.psc.2018.07.006","volume":"41","author":"P Tusiani-Eng","year":"2018","unstructured":"Tusiani-Eng P, Yeomans F. Borderline personality disorder: Barriers to borderline personality disorder treatment and opportunities for advocacy. Psychiatr Clin North Am. 2018;41(4):695\u2013709. https:\/\/doi.org\/10.1016\/j.psc.2018.07.006.","journal-title":"Psychiatr Clin North Am"},{"issue":"2","key":"1558_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1176\/appi.ps.201600108","volume":"68","author":"MC Lohman","year":"2017","unstructured":"Lohman MC, Whiteman KL, Yeomans FE, Cherico SA, Christ WR. Qualitative analysis of resources and barriers related to treatment of borderline personality disorder in the united states. Psychiatr Serv. 2017;68(2):167\u201372. https:\/\/doi.org\/10.1176\/appi.ps.201600108.","journal-title":"Psychiatr Serv"},{"issue":"3","key":"1558_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1037\/ccp0000870","volume":"92","author":"DS Spina","year":"2024","unstructured":"Spina DS, Levy KN. The availability of dialectical behavior therapy in partial hospitalization and residential services for borderline personality disorder: an exploratory longitudinal study of the National Mental Health Services Survey from 2014 to 2021. J Consult Clin Psychol. 2024;92(3):176\u201386. https:\/\/doi.org\/10.1037\/ccp0000870.","journal-title":"J Consult Clin Psychol"},{"issue":"4\u20136","key":"1558_CR29","first-page":"53","volume":"20","author":"D Vanderpool","year":"2023","unstructured":"Vanderpool D. Risk management: Treating patients at risk for suicide: Part 1. Innov Clin Neurosci. 2023;20(4\u20136):53\u20135.","journal-title":"Innov Clin Neurosci."},{"issue":"6","key":"1558_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40263-023-01015-6","volume":"37","author":"JC * Pascual","year":"2023","unstructured":"* Pascual JC, Arias L, Soler J. Pharmacological management of Borderline personality disorder and common comorbidities. CNS Drugs. 2023;37(6):489\u201397. https:\/\/doi.org\/10.1007\/s40263-023-01015-6.","journal-title":"CNS Drugs"},{"issue":"1","key":"1558_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40473-017-0103-z","volume":"4","author":"LW Choi-Kain","year":"2017","unstructured":"Choi-Kain LW, Finch EF, Masland SR, Jenkins JA, Unruh BT. What works in the treatment of Borderline personality disorder. Curr Behav Neurosci Rep. 2017;4(1):21\u201330. https:\/\/doi.org\/10.1007\/s40473-017-0103-z.","journal-title":"Curr Behav Neurosci Rep"},{"issue":"3","key":"1558_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/13651501.2019.1576904","volume":"23","author":"F Riffer","year":"2019","unstructured":"Riffer F, Farkas M, Streibl L, Kaiser E, Sprung M. Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines. Int J Psychiatry Clin Pract. 2019;23(3):178\u201388. https:\/\/doi.org\/10.1080\/13651501.2019.1576904.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"6","key":"1558_CR33","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1192\/bjo.2023.592","volume":"9","author":"M Tennant","year":"2023","unstructured":"* *Tennant M, Frampton C, Mulder R, Beaglehole B. Polypharmacy in the treatment of people diagnosed with borderline personality disorder: repeated cross- sectional study using New Zealand\u2019s national databases. BJ Psych 26. 2023;9(6):e200. https:\/\/doi.org\/10.1192\/bjo.2023.592.","journal-title":"BJ Psych 26"},{"issue":"2","key":"1558_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/HRP.0000000000000200","volume":"27","author":"SK Fineberg","year":"2019","unstructured":"Fineberg SK, Gupta S, Leavitt J. Collaborative deprescribing in Borderline personality disorder: a narrative review. Harv Rev Psychiatry. 2019;27(2):75\u201386. https:\/\/doi.org\/10.1097\/HRP.0000000000000200.","journal-title":"Harv Rev Psychiatry"},{"issue":"7","key":"1558_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1176\/ps.31.7.479","volume":"31","author":"TG Gutheil","year":"1980","unstructured":"Gutheil TG. Paranoia and progress notes: a guide to forensically informed psychiatric recordkeeping. Hosp Community Psychiatry. 1980;31(7):479\u201382. https:\/\/doi.org\/10.1176\/ps.31.7.479.","journal-title":"Hosp Community Psychiatry"},{"issue":"4","key":"1558_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1176\/appi.focus.20220054","volume":"20","author":"RG Hersh","year":"2022","unstructured":"Hersh RG. Review of contemporary risk management challenges in the treatment of patients with borderline personality disorder. Focus (Am Psychiatr Publ). 2022;20(4):353\u20137. https:\/\/doi.org\/10.1176\/appi.focus.20220054.","journal-title":"Focus (Am Psychiatr Publ)"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-024-01558-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-024-01558-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-024-01558-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T22:06:06Z","timestamp":1736287566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-024-01558-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1558"],"URL":"https:\/\/doi.org\/10.1007\/s11920-024-01558-5","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"type":"print","value":"1523-3812"},{"type":"electronic","value":"1535-1645"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"25 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}